Analgesic acitivity of namoxyrate (2-[4-biphenylyl] butyric acid 2-dimethylaminoethanol salt).
D000605:Amino Alcohols / Q000494:pharmacology; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D001713:Biphenyl Compounds / Q000494:pharmacology*; D001920:Bradykinin; D002087:Butyrates / Q000494:pharmacology; D003061:Codeine / Q000494:pharmacology; D011431:Dextropropoxyphene / Q000494:pharmacology; D005260:Female; D008614:Meperidine / Q000494:pharmacology; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D010636:Phenols / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D011809:Quinones; D051381:Rats; D012640:Seizures / Q000139:chemically induced
D000605:Amino Alcohols; D000700:Analgesics; D001713:Biphenyl Compounds; D002087:Butyrates; D010636:Phenols; D010880:Piperidines; D011809:Quinones; D009020:Morphine; D008614:Meperidine; D010653:Phenylbutazone; D001241:Aspirin; D011431:Dextropropoxyphene; D001920:Bradykinin; D003061:Codeine